VECT-HORUS

  • Total Funding$29.4 M

OverviewSuggest Edit

VECT-HORUS is a biotech company that develops peptide-based vectors to facilitate the delivery of drugs or imaging agents into the brain and to tumors. It focuses on targeted delivery by conjugating therapeutics or imaging agents to “molecular vectors” that specifically target receptors involved in receptor mediated transport (RMT) in order to bypass cell barriers for delivering biomolecules.

TypePrivate
Founded2005
HQMarseille, FRMap
Websitevect-horus.com

Recent NewsAll News

Latest Updates

Employees (est.) (Jun 2022)34
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

VECT-HORUS Office Locations

VECT-HORUS has an office in Marseille
Marseille, FR (HQ)
27 Bd Jean Moulin
Show all (1)

VECT-HORUS Financials and Metrics

Summary Metrics

Founding Date

2005

VECT-HORUS total Funding

$29.4 m

VECT-HORUS latest funding size

$14.55 m

Time since last funding

a year ago

VECT-HORUS investors

CAAP Creation, Financière Tuileries Co-Invest, SCR Provençale et Corse
VECT-HORUS's latest funding round in January 2021 was reported to be $14.5 m. In total, VECT-HORUS has raised $29.4 m
Show all financial metrics

VECT-HORUS Cybersecurity Score

Cybersecurity ratingPremium dataset

B

81/100

Learn more about our premium products
SecurityScorecard logo

VECT-HORUS Online and Social Media Presence

VECT-HORUS's Trends

Embed Graph

VECT-HORUS Blogs

May 16, 2022

VECT-HORUS Strengthens its Scientific Advisory Board with the Appointment of Frédéric MATONTI

Vect-Horus extends its Scientific Advisory Board with the expertise of Frédéric Matonti, a Leading Ophthalmology Specialist. - News / Science, page_accueil_3_actus
March 22, 2022

VECT-HORUS Strengthens its Scientific Advisory Board with the Appointment of Dr. Julia Alterman

Vect-Horus extends its Scientific Advisory Board with the expertise of Dr. Julia Alterman on siRNA chemical modification for extra-hepatic delivery. - News / page_accueil_3_actus, Science
February 17, 2022

e-Meet VECT-HORUS at the digital BIO Europe Spring from March 28 to 31, 2022

Emmanuelle BETTENDORF will participate in BioEurope Spring from March 28 to 31, 2022 and will be available to meet with you on partnership opportunities. - News / Agenda, page_accueil_3_actus
January 17, 2022

Séminaire M&M's – Muscle Monday Seminars of the Institute's Myology Centre for Research

Michel Khrestchatisky (CNRS Research Director, Director of the Institute for Neurophysiopathology) Co-Founder & Scientific Counsel of Vect-Horus presents "Development of molecular vectors for targeted delivery of RNAi via receptor-mediated transport" at the Muscle Monday Seminars organized by th…
December 24, 2021

Happy new year !

The Vect-Horus teams join to wish you a Happy Holiday season and Best Wishes for 2022. - News / Agenda, page_accueil_3_actus
December 01, 2021

BiotechShowcase

Meet VECT-HORUS at the first 2022 partnering event from January 17th to January 19th, during the digital week. - News / Agenda, page_accueil_3_actus
Show more

 VECT-HORUS Frequently Asked Questions

  • When was VECT-HORUS founded?

    VECT-HORUS was founded in 2005.

  • How many employees does VECT-HORUS have?

    VECT-HORUS has 34 employees.

  • Who are VECT-HORUS competitors?

    Competitors of VECT-HORUS include Entrinsic Bioscience, A2 Biotherapeutics and Innate Pharma.

  • Where is VECT-HORUS headquarters?

    VECT-HORUS headquarters is located at 27 Bd Jean Moulin, Marseille.

  • Where are VECT-HORUS offices?

    VECT-HORUS has an office in Marseille.

  • How many offices does VECT-HORUS have?

    VECT-HORUS has 1 office.